$14.160
-0.538 (-3.80%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CRVS Prediction & Forecast by Similar Chart Analysis
Alphio's CRVS stock price prediction model matches the current Corvus Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.44 (+1.99%). The 1-week path is $14.20 (+0.29%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Corvus Pharmaceuticals Inc Stock?
Corvus Pharmaceuticals Inc is a good buy right now due to its current price of $14.16, which is significantly lower than the analyst price target of $40 from Goldman Sachs. Additionally, the stock has shown a remarkable year-to-date change of +93.44%, indicating strong momentum. However, a key risk is the negative earnings per share (EPS) of -0.19 reported for Q2 2026, which reflects ongoing losses.
CRVS stock price ended at $14.16 on Friday, after losing -3.80%
Corvus Pharmaceuticals Inc (CRVS) last closed at $14.16, losing -3.80%. These facts feed the 1-day and 1-week CRVS price prediction above.
Analyst Consensus
Corvus Pharmaceuticals Inc (CRVS): 5 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Corvus Pharmaceuticals Inc (CRVS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CRVS, ranked by similarity.
Seasonality analysis for CRVS
Historically the probability of a positive August return for CRVS is 74.60%. September offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CRVS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.59 | $3.93 | $4.12 | -72.23% |
| Sep 2026 | $4.78 | $4.96 | $5.57 | -64.95% |
| Oct 2026 | $3.76 | $4.24 | $5.14 | -70.03% |
| Nov 2026 | $3.46 | $4.05 | $4.05 | -71.41% |
| Dec 2026 | $4.37 | $5.15 | $5.78 | -63.63% |
In 2026, Corvus Pharmaceuticals Inc (CRVS) is projected to range from $3.46 to $5.78.
Corvus Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Corvus Pharmaceuticals Inc is projected to average $3.93, with a low of $3.59 and high of $4.12.
In Sep 2026, Corvus Pharmaceuticals Inc is projected to average $4.96, with a low of $4.78 and high of $5.57.
In Oct 2026, Corvus Pharmaceuticals Inc is projected to average $4.24, with a low of $3.76 and high of $5.14.
In Nov 2026, Corvus Pharmaceuticals Inc is projected to average $4.05, with a low of $3.46 and high of $4.05.
In Dec 2026, Corvus Pharmaceuticals Inc is projected to average $5.15, with a low of $4.37 and high of $5.78.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.